Implement Effective Comparability Studies to Overcome Strategic &

Technical Hurdles & Expedite More Gene Therapy Approvals 

Welcome to the 4th Annual Gene Therapy

Comparability Summit!

In the context of ever-important gene therapy scale-up to achieve commercial goals and mounting regulatory scrutiny, the 3rd Annual Gene Therapy Comparability Summit is the only event focused on comparability of gene therapy. Join 150+ Quality Assurance, CMC, Regulatory, Analytical and Process Development experts from pharma and biotechs to provide you with hands-on, practical insights into exactly what it takes to ensure you can maintain safety, quality, consistency, and efficacy while adapting manufacturing processes, methods and platforms, to adhere to regulatory demands and avoid costly delays to clinical programs.

With two recent approvals there has been a resurgence surrounding gene therapy, so comparability continues to be of upmost importance, and is at the forefront of the communities minds due to push-back from regulators.

This event involved likeminded individuals from across the Gene Therapy space, to give the attendees a hands-on and practical insight into methods to improve their comparability assessments.

4

DEEP DIVE WORKSHOPS

25+

EXPERT SPEAKERS

20+

case studies with insights

6+

HOURS OF NETWORKING

Expert Speakers Included:

Mariska ter Haak

Senior Director - Analytical Development

IN8bio

Ilya Shestopalov

Vice President, Analytical Development

bluebird bio

Miloud Georges Nichane

Senior Consultant (Validation, Quality & Regulatory)

Ellion

Santoshkumar khatwani

Director & Team Lead - Analytical Development, Late Stage, Chemistry, Manufacturing & Controls Analytical

Sangamo Therapeutics

Angela Coy

Senior Manager - Regulatory Affairs Chemistry, Manufacturing, & Controls

Forge Biologics